HLA class II neoantigen presentation for CD4+ T cell surveillance in HLA class II-negative colorectal cancer
Neoantigen-reactive CD4+ T cells play a key role in the anti-tumor immune response. However, the majority of epithelial tumors are negative for HLA class II (HLA-II) surface expression, and less is known about the processing of HLA-II antigens. Here, we directly identified naturally presented HLA-II...
Saved in:
| Main Authors: | Satoru Matsumoto, Takahiro Tsujikawa, Serina Tokita, Mai Mohamed Bedeir, Kazuhiko Matsuo, Fumitake Hata, Yoshihiko Hirohashi, Takayuki Kanaseki, Toshihiko Torigoe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | OncoImmunology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2024.2404665 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neoantigen prioritization based on antigen processing and presentation
by: Serina Tokita, et al.
Published: (2024-11-01) -
HLA class II-restricted T cell epitopes in public neoantigens of ESR1 and PIK3CA in breast cancer
by: Yukari Ando, et al.
Published: (2025-04-01) -
Shared neoantigens for cancer immunotherapy
by: Anastasia Goloudina, et al.
Published: (2025-06-01) -
Neoantigens: new hope for cancer therapy
by: Yitong Hu, et al.
Published: (2025-03-01) -
Neoantigen immunotherapy: a novel treatment for bladder cancer
by: Ruiyang Lv, et al.
Published: (2025-01-01)